微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 19.68% | 13.68% | -3% | 115/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 20.28% | 20.28% | -2.13% | 115/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 20.72% | 5% | 18.84% | 114/129 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 17.44% | -21.07% | 0.75% | 115/129 | 53.85% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 17.31% | -27.13% | 2.64% | 113/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 16.86% | -30.33% | -14.57% | 116/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 19.74% | -15.46% | -10.66% | 113/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 22.09% | -11.78% | -6.98% | 116/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 23.75% | -9.4% | -1.88% | 109/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 24.21% | -4.89% | 3.68% | 113/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 23.35% | 2% | -6.77% | 104/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 25.04% | -2.04% | -4.47% | 116/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 26.22% | 2% | 3.01% | 100/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 25.45% | -16.9% | -0.45% | 109/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 25.56% | -15.77% | -16.52% | 118/129 | 59.67% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 30.63% | 9.35% | 0.9% | 102/129 | 59.94% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 30.35% | 0.06% | 0.06% | 102/129 | 56.37% | 正海生物 | 92.69% | 行业排名> |
| 2018-12-31 | 30.33% | 2.63% | 2.63% | 97/129 | 55.53% | 正海生物 | 92.61% | 行业排名> |
| 2017-12-31 | 29.56% | -9.64% | 5.53% | 93/129 | 55.34% | 正海生物 | 94.38% | 行业排名> |
| 2016-06-30 | 28.01% | -14.49% | -14.38% | 46/129 | 51.46% | 正海生物 | 93.12% | 行业排名> |
| 2015-12-31 | 32.71% | 2% | -0.13% | 49/129 | 53.26% | 正海生物 | 93.78% | 行业排名> |
| 2015-06-30 | 32.75% | 2% | 2% | 35/129 | 51.86% | 正海生物 | 93.09% | 行业排名> |